Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]Gerke V, Moss SE: Annexins: from structure to function. Physiol Rev 82(2), 331-71 (2002)

  • [2]Hayes MJ, Moss SE: Annexins and disease. Biochem Biophys Res Commun 322(4), 1166-70 (2004)

  • [3]Mussunoor S, Murray GI: The role of annexins in tumour development and progression. J Pathol 216(2),131-40 (2008)

  • [4]Fatimathas L, Moss SE: Annexins as disease modifiers. Histol Histopathol 25(4), 527-32 (2010)

  • [5]Zanotti G, Malpeli G, Gliubich F, Folli C, Stoppini M, Olivi L: Structure of the trigonal crystal form of bovine annexin IV. Biochem J 329 (Pt 1), 101-6 (1998)

  • [6]Kaetzel MA, Mo YD, Mealy TR, Campos B, Bergsma-Schutter W, Brisson A: Phosphorylation mutants elucidate the mechanism of annexin IV-mediated membrane aggregation. Biochemistry 40(13), 4192-9 (2001)

  • [7]Oling F, Santos JS, Govorukhina N, Mazeres-Dubut C, Bergsma-Schutter W, Oostergetel G: Structure of membrane-bound annexin A5 trimers: a hybrid cryo-EM - X-ray crystallography study. J Mol Biol 304(4), 561-73 (2000)

  • [8]Lee AY, Park BC, Jang M, Cho S, Lee DH, Lee SC: Identification of caspase-3 degradome by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 4(11), 3429-36 (2004)

  • [9]Jastrzebski K, Hannan KM, House CM, Hung SS, Pearson RB, Hannan RD: A phospho-proteomic screen identifies novel S6K1 and mTORC1 substrates revealing additional complexity in the signaling network regulating cell growth. Cell Signal 23(8), 1338-47 (2011)

  • [10]Jeon YJ, Kim DH, Jung H, Chung SJ, Chi SW, Cho S: Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner. Cell Mol Life Sci 67(13), 2271-81 (2010)

  • [11]Lin LL, Huang HC, Juan HF: Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays. PLoS One 7(9), e44615 (2012)

  • [12]Duncan R, Carpenter B, Main LC, Telfer C, Murray GI: Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98(2), 426-33 (2008)

  • [13]Alfonso P, Canamero M, Fernandez-Carbonie F, Nunez A, Casal JI: Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. J Proteome Res 7(10), 4247-55 (2008)

  • [14]Deng S, Wang J, Hou L, Li J, Chen G, Jing B: Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically. Oncol Lett 5(1), 107-12 (2013)

  • [15]Zimmermann U, Balabanov S, Giebel J, Teller S, Junker H, Schmoll D: Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 209(1), 111-8 (2004)

  • [16]Wei R, Zhang Y, Shen L, Jiang W, Li C, Zhong M: Comparative proteomic and radiobiological analyses in human lung adenocarcinoma cells. Mol Cell Biochem 359(1-2), 151-9 (2012)

  • [17]Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA: Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 162(1), 255-61 (2003)

  • [18]Huang HL, Yao HS, Wang Y, Wang WJ, Hu ZQ, Jin KZ: Proteomic identification of tumor biomarkers associated with primary gallbladder cancer. World J Gastroenterol 20(18), 5511-8 (2014)

  • [19]Shen J, Person MD, Zhu J, Abbruzzese JL, Li D: Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64(24), 9018-26 (2004)

  • [20]Chen Y, Yao Y, Zhang L, Li X, Wang Y, Zhao L: cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer. Exp Mol Pathol 91(1), 373-84 (2011)

  • [21]Mogami T, Yokota N, Asai-Sato M, Yamada R, Koizume S, Sakuma Y: Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells. PLoS One 8(11), e80359 (2013)

  • [22]Dreier R, Schmid KW, Gerke V, Riehemann K: Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem Cell Biol 110(2), 137-48 (1998)

  • [23]Lin LL, Chen CN, Lin WC, Lee PH, Chang KJ, Lai YP: Annexin A4: A novel molecular marker for gastric cancer with Helicobacter pylori infection using Proteomics approach. Proteomics Clin Appl 2(4), 619-34 (2008)

  • [24]Li H, Guo L, Li JW, Liu N, Qi R, Liu J: Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. Int J Oncol 17(5), 927-32 (2000)

  • [25]Maxwell CA, McCarthy J, Turley E: Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci 121(Pt 7), 925-32 (2008)

  • [26]Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S: Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 82(1), 19-26 (1995)

  • [27]Chen YR, Juan HF, Huang HC, Huang HH, Lee YJ, Liao MY: Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. J Proteome Res 5(10), 2727-42 (2006)

  • [28]Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, Jr., Mayo MW: Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20(5), 1626-38 (2000)

  • [29]Hunter T, Pines J: Cyclins and cancer. Cell 66(6), 1071-4 (1991)

  • [30]Banerjee SK, Weston AP, Zoubine MN, Campbell DR, Cherian R: Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma: relationship to cell death, proliferation, and transformation. Am J Pathol 156(1), 217-25 (2000)

  • [31]Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24(11), 1770-83 (2006)

  • [32]Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM: Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 62(16), 4722-9 (2002)

  • [33]Morita A, Miyagi E, Yasumitsu H, Kawasaki H, Hirano H, Hirahara F: Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma. Proteomics 6(21), 5880-90 (2006)

  • [34]Toyama A, Suzuki A, Shimada T, Aoki C, Aoki Y, Umino Y: Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers. Cancer Sci 103(4), 747-55 (2012)

  • [35]Choi CH, Sung CO, Kim HJ, Lee YY, Song SY, Song T: Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary. Hum Pathol 44(6), 1017-23 (2013)

  • [36]Kim A, Enomoto T, Serada S, Ueda Y, Takahashi T, Ripley B: Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. Int J Cancer 125(10), 2316-22 (2009)

  • [37]Markoff A, Gerke V: Expression and functions of annexins in the kidney. Am J Physiol Renal Physiol 289(5), F949-56 (2005)

  • [38]Jeon YJ, Kim J, Chae JI: Comparative proteomic analysis of kidney development-related proteins in the pig. In vitro Cell Dev Biol Anim 49(5), 315-23 (2013)

  • [39]Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M: Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 3(8), 1620-32 (2003)

  • [40]Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63(1), 11-30 (2013)

  • [41]Haiman CA, Han Y, Feng Y, Xia L, Hsu C, Sheng X: Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population. PLoS Genet 9(3), e1003419 (2013)

  • [42]Alfonso P, Nunez A, Madoz-Gurpide J, Lombardia L, Sanchez L, Casal JI: Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 5(10), 2602-11 (2005)

  • [43]Wang JJ, Liu Y, Zheng Y, Lin F, Cai GF, Yao XQ: Comparative Proteomics analysis of colorectal cancer. Asian Pac J Cancer Prev 13(4), 1663-6 (2012)

  • [44]Sitek B, Luttges J, Marcus K, Kloppel G, Schmiegel W, Meyer HE: Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma. Proteomics 5(10), 2665-79 (2005)

  • [45]Sitek B, Sipos B, Alkatout I, Poschmann G, Stephan C, Schulenborg T: Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J Proteome Res 8(4), 1647-56 (2009)

  • [46]Han EK, Tahir SK, Cherian SP, Collins N, Ng SC: Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer 83(1), 83-8 (2000)

  • [47]Yamashita T, Nagano K, Kanasaki S, Maeda Y, Furuya T, Inoue M: Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells. Biochem Biophys Res Commun 421(1), 140-4 (2012)

  • [48]Morimoto A, Serada S, Enomoto T, Kim A, Matsuzaki S, Takahashi T: Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner. Oncotarget 5(17), 7776-87 (2014)

  • [49]Matsuzaki S, Enomoto T, Serada S, Yoshino K, Nagamori S, Morimoto A: Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A. Int J Cancer 134(8), 1796-809 (2014)

  • [50]Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441 (7092), 431-6 (2006)

  • [51]Baud V, Karin M: Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8(1), 33-40 (2009)

  • [52]Salerno M, Yahia D, Dzamitika S, de Vries E, Pereira-Maia E, Garnier-Suillerot A: Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells. J Biol Inorg Chem 14(1), 123-32 (2009)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jun 2016Review

The role of annexin A4 in cancer

Houshan Yao 1, Chang Sun 1, Zhiqian Hu 1, Weijun Wang 1,*
Affiliation
Article Info

1 Department of General Surgery, Shanghai Chang Zheng Hospital, Second Military Medical University, Shanghai 200003, China

Abstract

Annexin A4 (ANXA4) is a member of the annexin family that binds to both calcium ions and phospholipids. Studies indicate that ANXA4 modulates membrane permeability and membrane trafficking, participates in cellular growth and apoptosis, enhances tumor invasion and promotes anti-tumor drug resistance. The overexpression of ANXA4 has been identified in various clinical epithelial tumors including: lung, gastric, colorectal, pancreatic, gallbladder, breast, renal, ovarian, laryngeal, and prostate cancers. In addition, upregulation and nuclear translocation of ANXA4 have been observed in the progression of colorectal cancer and ovarian serous carcinoma. Knockdown of ANXA4 attenuated migration in ovarian cancer and breast cancer cells. In contrast, knockdown of ANXA4 increased susceptibility to platinum in ovarian cancer and malignant mesothelioma cells. It is conceivable that ANXA4 is an indicator for tumor development, invasion, chemo-resistance, poor outcomes of cancer patients, and may be a potential target for therapeutic intervention.

Keywords

  • Annexin A4
  • Cancer
  • Chemo-Resistance
  • Review

References